SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 49 filers reported holding SIGILON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,961,766 | +428.5% | 2,109,200 | +98.9% | 0.00% | – |
| Q4 2022 | $371,181 | -30.9% | 1,060,516 | -0.3% | 0.00% | – |
| Q3 2022 | $537,000 | -39.3% | 1,063,300 | -0.3% | 0.00% | – |
| Q2 2022 | $885,000 | -43.6% | 1,066,600 | -0.1% | 0.00% | – |
| Q1 2022 | $1,568,000 | -46.8% | 1,067,327 | -0.1% | 0.00% | – |
| Q4 2021 | $2,950,000 | -44.0% | 1,068,700 | +14.7% | 0.00% | – |
| Q3 2021 | $5,264,000 | -36.5% | 931,742 | +20.5% | 0.00% | -100.0% |
| Q2 2021 | $8,294,000 | -54.3% | 773,000 | -4.7% | 0.00% | -50.0% |
| Q1 2021 | $18,130,000 | -60.4% | 811,200 | -15.0% | 0.00% | -50.0% |
| Q4 2020 | $45,840,000 | – | 954,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 740,740 | $35,578,000 | 13.90% |
| Flagship Pioneering Inc. | 10,370,369 | $498,089,000 | 9.07% |
| Monashee Investment Management LLC | 561,628 | $26,975,000 | 3.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 567,460 | $26,061,000 | 2.31% |
| Avidity Partners Management LP | 688,000 | $33,045,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 225,000 | $10,807,000 | 0.76% |
| Artal Group S.A. | 276,000 | $13,256,000 | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 662,227 | $31,807,000 | 0.16% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,485,185 | $71,333,000 | 0.11% |
| Perceptive Advisors | 125,000 | $6,004,000 | 0.06% |